학술논문
Noncardiovascular deaths are more common than cardiovascular deaths in patients with cardiovascular disease or cardiovascular risk factors and impaired glucose tolerance: Insights from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial
Document Type
Article
Author
Source
In: American Heart Journal . (American Heart Journal, 1 April 2017, 186:73-82)
Subject
Language
English
ISSN
10976744
00028703
00028703